<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph B Cantey, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Karen M Puopolo, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Sepsis is an important cause of morbidity and mortality among newborn infants. Although the incidence of sepsis in term and late preterm neonates is low, the potential for serious adverse outcomes is of such great consequence that caregivers should have a low threshold for evaluation and treatment for possible sepsis in neonates.</p><p>The epidemiology, clinical features, diagnosis, and evaluation of bacterial sepsis in term and late preterm neonates will be reviewed here. The management and outcome of bacterial sepsis in term and late preterm neonates are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates"</a>.)</p><p>Other related topics include:</p><p class="bulletIndent1"><span class="glyph">●</span>Sepsis in preterm neonates (see  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation"</a> and  <a class="medical medical_review" href="/z/d/html/89456.html" rel="external">"Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Group B streptococcal (GBS) infection in neonates and infants, including management of well-appearing newborns at risk for GBS (see  <a class="medical medical_review" href="/z/d/html/5961.html" rel="external">"Group B streptococcal infection in neonates and young infants"</a> and  <a class="medical medical_review" href="/z/d/html/5981.html" rel="external">"Management of neonates at risk for early-onset group B streptococcal infection"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Outpatient evaluation and management of febrile neonates (see  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation and management of ill-appearing infants (see  <a class="medical medical_review" href="/z/d/html/6467.html" rel="external">"Approach to the ill-appearing infant (younger than 90 days of age)"</a>)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>The following terms will be used throughout this discussion on neonatal sepsis:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Term neonates</strong> are those born at a gestational age [GA] ≥37 weeks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late preterm</strong> <strong>neonates</strong> (also called near-term neonates) are those born from 34 to &lt;37 weeks GA [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/5034.html" rel="external">"Late preterm infants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neonatal sepsis</strong> is a clinical syndrome in an infant 28 days of life or younger, manifested by systemic signs of infection and isolation of a bacterial pathogen from the bloodstream. (See <a class="local">'Diagnosis'</a> below.)</p><p></p><p class="bulletIndent1">Sepsis is classified according to the neonate's age at the onset of symptoms.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Early-onset sepsis (EOS)</strong> is defined as the onset of symptoms before 72 hours of age [<a href="#rid2">2-4</a>], although some experts extend the definition to infections occurring within the first seven days after birth. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Late-onset sepsis (LOS) </strong>is generally defined as the onset of symptoms at ≥72 hours of age [<a href="#rid2">2</a>]. Similar to EOS, there is variability in the definition, ranging from an onset at &gt;72 hours of life to ≥7 days of age.</p><p></p><p class="bulletIndent1">Newborn infants with EOS typically present with symptoms during their birth hospitalization. Term neonates with LOS generally present to the outpatient setting or emergency department unless comorbid conditions have prolonged the birth hospitalization. The approach to evaluating febrile neonates in the outpatient setting is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on 'Neonates 8 to 21 days old'</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis differs based on the timing of onset:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early-onset sepsis (EOS)</strong> – EOS is usually due to vertical transmission of maternal genitourinary and gastrointestinal flora during vaginal delivery or by ascending contaminated amniotic fluid [<a href="#rid3">3</a>]. Maternal chorioamnionitis (or intra-amniotic infection) is a well-recognized risk factor for EOS [<a href="#rid5">5,6</a>]. Maternal group B streptococcal (GBS) colonization is another important risk factor. (See <a class="local">'Maternal risk factors'</a> below and  <a class="medical medical_review" href="/z/d/html/5961.html" rel="external">"Group B streptococcal infection in neonates and young infants", section on 'Risk factors'</a>.)</p><p></p><p class="bulletIndent1">Use of forceps during delivery and electrodes placed for intrauterine monitoring have been implicated in the pathogenesis of EOS because they penetrate the neonatal defensive epithelial barriers [<a href="#rid7">7</a>]. However, it is unclear if these are independent risk factors.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-onset sepsis (LOS)</strong> – LOS can be acquired by the following mechanisms:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Vertical transmission, resulting in initial neonatal colonization that evolves into later infection</p><p class="bulletIndent2"><span class="glyph">•</span>Horizontal transmission from contact with care providers or environmental sources</p><p></p><p class="bulletIndent1">Disruption of the intact skin or mucosa, which can be due to invasive procedures (eg, intravascular catheter), increases the risk of LOS. LOS is uncommonly associated with maternal obstetrical complications.</p><p></p><p>Metabolic factors including hypoxia, acidosis, hypothermia, and inherited metabolic disorders (eg, galactosemia) are likely to contribute to risk for and severity of neonatal sepsis (including both EOS and LOS). These factors are thought to disrupt the neonate's host defenses (ie, immunologic response) [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H6"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Estimated incidence rates vary based on the case definition and population studied. In a systematic review and meta-analysis of population-based studies from around the world, reported rates of neonatal sepsis varied widely, from as low as four cases per 100,000 in resource-abundant countries to as high as 170 cases per 100,000 live births in resource-limited countries [<a href="#rid8">8</a>]. The overall pooled incidence of neonatal sepsis worldwide was 22 per 1000 live births, with an associated mortality rate of 11 to 19 percent [<a href="#rid8">8</a>]. This translates to a global incidence of three million cases of neonatal sepsis per year [<a href="#rid8">8</a>]. Globally, neonatal sepsis and other severe infections were responsible for an estimated 430,000 neonatal deaths in 2013, accounting for approximately 15 percent of all neonatal deaths [<a href="#rid9">9</a>].</p><p>Rates of neonatal sepsis increase with decreasing gestational age (GA):</p><p class="bulletIndent1"><span class="glyph">●</span>Term neonates (GA ≥37 weeks) – The estimated incidence of bacterial sepsis (including both early- and late-onset) in term neonates is approximately 1 to 2 cases per 1000 live births [<a href="#rid10">10-14</a>]. Early-onset sepsis (EOS) accounts for approximately one-third to one-half of all cases. For example, in a surveillance study from the United States from 2015 to 2017, the incidence of EOS among term newborns was 0.6 cases per 1000 live births.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Late preterm neonates (GA 34 to &lt;37 weeks) – Late preterm neonates have a slightly higher risk of bacterial sepsis, with estimated incidence rates of approximately four to five cases per 1000 [<a href="#rid13">13,15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preterm neonates &lt;34 weeks gestational age – In preterm neonates, the incidence of bacterial sepsis increases with decreasing GA, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Incidence'</a>.)</p><p></p><p>The incidence of EOS in the United States has decreased, primarily due to reduction in group B streptococcal (GBS) infections, owing to the use of intrapartum antibiotic prophylaxis (IAP) [<a href="#rid16">16-20</a>]. Early-onset GBS infection rates in the United States reported through the Centers for Disease Control and Prevention's Active Bacterial Core Surveillance Report have declined from 0.6 per 1000 live births in 2000 to 0.2 per 1000 live births in 2021 [<a href="#rid21">21,22</a>]. Over the same interval, rates of late-onset GBS infection have remained stable at approximately 0.3 to 0.4 cases per 1000 live births, with relatively little year-to-year variation [<a href="#rid21">21,22</a>]. (See  <a class="medical medical_review" href="/z/d/html/5961.html" rel="external">"Group B streptococcal infection in neonates and young infants", section on 'Epidemiology'</a>.)</p><p>GBS prevention efforts have not increased the burden of early-onset <em>Escherichia</em> <em>coli</em> infection [<a href="#rid23">23</a>]. </p><p class="headingAnchor" id="H7"><span class="h1">ETIOLOGIC AGENTS</span><span class="headingEndMark"> — </span>Group B <em>Streptococcus</em> (GBS) and <em>E.</em> <em>coli</em> are the most common causes of both EOS and LOS, accounting for approximately two-thirds of early-onset infections [<a href="#rid13">13,17,23,24</a>].</p><p>Other bacterial agents associated with neonatal sepsis include (<a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><em>Listeria</em> <em>monocytogenes</em>, although a well-recognized cause of EOS, only accounts for rare sporadic cases of neonatal sepsis and is more commonly seen during an outbreak of listeriosis [<a href="#rid25">25,26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Staphylococcus</em> <em>aureus</em>, including community-acquired methicillin-resistant <em>S</em>. <em>aureus</em>, is a potential pathogen in late-onset sepsis [<a href="#rid27">27</a>]. In term neonates, <em>S. aureus</em> bacteremia most commonly occurs in association with skin, bone, or joint infections. <em>S. aureus </em>is a more common pathogen in preterm neonates. (See  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Etiologic agents'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Enterococcus</em>, a commonly encountered pathogen among preterm neonates, is a rare cause of sepsis in otherwise healthy term newborn infants.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other gram-negative bacteria (including <em>Klebsiella</em>, <em>Enterobacter</em>, and <em>Citrobacter</em> spp) and <em>Pseudomonas</em> <em>aeruginosa</em> are associated with LOS, especially in neonates admitted to neonatal intensive care units [<a href="#rid28">28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coagulase-negative staphylococci often are a cause of hospital-associated infection in ill neonates (primarily in preterm neonates and/or neonates who have indwelling intravascular catheters). Coagulase-negative staphylococci may be considered a contaminant in otherwise healthy term neonates who have not undergone invasive procedures. (See  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'CoNS: Pathogen or contaminant?'</a>.)</p><p></p><p>Common nonbacterial agents associated with neonatal sepsis include (see <a class="local">'Differential diagnosis'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Herpes simplex virus (see  <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">"Neonatal herpes simplex virus infection: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enterovirus and parechovirus (see  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Candida</em> (see  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Invasive infection'</a>)</p><p></p><p class="headingAnchor" id="H96556694"><span class="h1">MATERNAL RISK FACTORS</span><span class="headingEndMark"> — </span>Maternal factors that are associated with an increased risk of EOS in the neonate, particularly group B <em>Streptococcus</em> (GBS) infection, include intra-amniotic infection (clinical chorioamnionitis), intrapartum maternal fever, maternal GBS colonization, preterm birth, and prolonged rupture of the membranes (PROM) [<a href="#rid3">3,5,29</a>]. The approach to identifying pregnancies at risk for neonatal EOS and indications for maternal intrapartum antibiotic prophylaxis (IAP) are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Identification of pregnancies at increased risk for early-onset neonatal GBS'</a> and  <a class="medical medical_review" href="/z/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Intrapartum antibiotic prophylaxis'</a>.)</p><p>Maternal GBS screening and IAP reduce the risk of GBS infection but do not eliminate it. In an analysis of 1277 neonates with early-onset GBS infection, only 30 percent of mothers had received IAP prior to delivery (though in most of these cases, IAP was started &lt;4 hours before delivery) [<a href="#rid30">30</a>]. Among newborns who were born to mothers who did not receive IAP, there were indications for maternal IAP in one-third of cases (ie, missed opportunities), whereas two-thirds did not have indications for maternal IAP (eg, negative maternal GBS screening).</p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Clinical manifestations range from subtle symptoms to profound septic shock. Signs and symptoms of sepsis are nonspecific and include temperature instability (hypothermia or fever), irritability, lethargy, respiratory symptoms (eg, tachypnea, grunting, hypoxia), poor feeding, tachycardia, poor perfusion, and hypotension (<a class="graphic graphic_table graphicRef72985" href="/z/d/graphic/72985.html" rel="external">table 2</a>) [<a href="#rid7">7</a>].</p><p>Because the signs and symptoms of sepsis can be subtle and nonspecific, it is important to identify neonates with risk factors for sepsis and to have a high index of suspicion for sepsis when a newborn deviates from their usual pattern of activity or feeding [<a href="#rid7">7</a>].</p><p>Signs and symptoms of neonatal sepsis include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fetal and delivery room distress</strong> – The following signs of fetal and neonatal distress during labor and delivery may be early indicators of neonatal sepsis:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intrapartum fetal tachycardia, which may be due to intra-amniotic infection (see  <a class="medical medical_review" href="/z/d/html/6765.html" rel="external">"Fetal arrhythmias", section on 'Tachyarrhythmias'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Meconium-stained amniotic fluid, which is associated with a twofold increased risk of sepsis [<a href="#rid5">5</a>] (see  <a class="medical medical_review" href="/z/d/html/4971.html" rel="external">"Meconium aspiration syndrome: Pathophysiology, clinical manifestations, and diagnosis", section on 'Meconium composition and passage'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Low 5- or 10-minute Apgar score, particularly if concerning findings persist (see  <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">"Overview of the routine management of the healthy newborn infant", section on 'Apgar score'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Temperature instability</strong> – The temperature of an infected neonate can be elevated, depressed, or normal. Term neonates with sepsis are more likely to mount a febrile response to infection; whereas preterm neonates are more likely to be hypothermic [<a href="#rid7">7</a>]. In term newborns, persistent fever is highly indicative of infection [<a href="#rid31">31,32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiorespiratory symptoms</strong> – Respiratory and cardiocirculatory symptoms are common in infected neonates. Approximately 85 percent of newborns with EOS present with respiratory distress (eg, tachypnea, grunting, flaring, use of accessory muscles) [<a href="#rid12">12</a>]. EOS can be associated with persistent pulmonary hypertension of the newborn. (See  <a class="medical medical_review" href="/z/d/html/5045.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">Apnea is less common, occurring in 30 to 40 percent of cases, and is more likely in preterm than term neonates. Apnea is a classic presenting symptom in late-onset group B streptococcal (GBS) sepsis. </p><p></p><p class="bulletIndent1">Tachycardia is a common finding in neonatal sepsis but is nonspecific. Bradycardia may also occur. Poor perfusion and hypotension are more sensitive indicators of sepsis, but these tend to be late findings. In a prospective national surveillance study, 40 percent of neonates with sepsis required volume expansion, and 29 percent required vasopressor support [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurologic symptoms</strong> – Neurologic manifestations of sepsis in the neonate include lethargy, poor tone, poor feeding, irritability, and seizures [<a href="#rid7">7</a>]. Seizures are an uncommon presentation of neonatal sepsis but are associated with a high likelihood of infection. In a prospective study in a single neonatal unit, 38 percent of neonates with seizures had sepsis as the etiology [<a href="#rid33">33</a>]. Seizures are a presenting feature in 20 to 50 percent of neonates with neonatal meningitis [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/z/d/html/6005.html" rel="external">"Bacterial meningitis in the neonate: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6179.html" rel="external">"Etiology and prognosis of neonatal seizures"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other findings</strong> – Other findings associated with neonatal sepsis, and their approximate frequencies are listed below (<a class="graphic graphic_table graphicRef72985" href="/z/d/graphic/72985.html" rel="external">table 2</a>) [<a href="#rid7">7,12</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Jaundice – 35 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Hepatomegaly – 33 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Poor feeding – 28 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Vomiting – 25 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Abdominal distension – 17 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Diarrhea – 11 percent</p><p></p><p class="headingAnchor" id="H12"><span class="h1">EVALUATION AND INITIAL MANAGEMENT</span><span class="headingEndMark"> — </span>Neonates with clinical signs of sepsis (<a class="graphic graphic_table graphicRef72985" href="/z/d/graphic/72985.html" rel="external">table 2</a>) require prompt evaluation and initiation of antibiotic therapy [<a href="#rid3">3,7</a>]. Because the signs and symptoms of sepsis are subtle and nonspecific, the threshold for performing laboratory testing is low. Our approach is generally consistent with guidelines published by the American Academy of Pediatrics [<a href="#rid3">3,35</a>]. (See <a class="local">'Society guideline links'</a> below.)</p><p class="headingAnchor" id="H103627438"><span class="h2">Early-onset presentation</span><span class="headingEndMark"> — </span>The evaluation of a neonate with suspected EOS (onset within first 72 hours after birth) includes all of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Review of the pregnancy, labor, and delivery, including risk factors for sepsis and the use and duration of maternal intrapartum antibiotic prophylaxis (IAP). (See <a class="local">'Maternal risk factors'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>Comprehensive physical examination. (See  <a class="medical medical_review" href="/z/d/html/4984.html" rel="external">"Assessment of the newborn infant"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory testing – The extent of the evaluation is directed by the neonate's signs and symptoms (if present) and maternal risk factors, as discussed in the following sections. </p><p></p><p class="headingAnchor" id="H191270180"><span class="h3">Early-onset sepsis calculator</span><span class="headingEndMark"> — </span>A multivariate predictive model for determining the risk of EOS, the EOS calculator, has been developed and validated in various clinical settings [<a href="#rid29">29,36-38</a>]. The EOS calculator is a web-based tool that can be used to estimate the risk of EOS in individual patients based on risk factors (eg, newborn clinical condition, highest intrapartum maternal temperature, maternal group B <em>Streptococcus</em> [GBS] status, administration of maternal IAP, gestational age, duration of rupture of membranes). The calculator requires the user to input the local incidence of EOS. If the local incidence of EOS is unknown, the users should enter "0.5 per 1000." The calculator provides guidance on whether diagnostic evaluation and empiric antibiotic treatment are warranted. The threshold used to trigger evaluation and empiric treatment varies, depending on the clinical circumstances. The EOS calculator is <strong>not</strong> valid for preterm neonates (&lt;34 weeks gestation) and does not apply to LOS.</p><p class="headingAnchor" id="H2041314197"><span class="h3">Symptomatic neonates</span><span class="headingEndMark"> — </span>Neonates with clinical signs of EOS (<a class="graphic graphic_table graphicRef72985" href="/z/d/graphic/72985.html" rel="external">table 2</a>) without a clear alternative explanation (eg, delayed transition, retained fetal lung fluid) should undergo a full diagnostic evaluation and should receive empiric antibiotic treatment. (See <a class="local">'Empiric antibiotic therapy'</a> below.)</p><p>The evaluation includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood culture. (See <a class="local">'Blood culture'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lumbar puncture (LP) – Practice has shifted regarding performing LP in neonates undergoing evaluation for clinically suspected EOS [<a href="#rid3">3</a>]. In our practice, we perform LP if the newborn is ill-appearing (provided they can tolerate the procedure) or if there are other concerning signs (irritability, bulging fontanelle, seizures). In addition, if the blood culture is positive, then LP should be performed [<a href="#rid3">3</a>]. Other experts advise performing LP in all neonates undergoing evaluation for clinically suspected EOS. (See <a class="local">'Lumbar puncture'</a> below.) </p><p></p><p class="bulletIndent1">LP is <strong>not</strong> necessary in well-appearing newborns undergoing evaluation for EOS based upon identified risk factors, as discussed below. (See <a class="local">'Well-appearing neonates'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chest radiograph if there are respiratory findings.</p><p></p><p class="headingAnchor" id="H96559478"><span class="h3">Well-appearing neonates</span><span class="headingEndMark"> — </span>Well-appearing newborns with identified risk factors for EOS, particularly GBS, should be observed for 36 to 48 hours. Based on the nature of the risk factor(s) and the use and duration of maternal IAP, they may require a limited diagnostic evaluation (ie, blood culture). Accepted approaches to determining the need for laboratory evaluation and empiric antibiotics include categorical risk assessment (<a class="graphic graphic_algorithm graphicRef56780" href="/z/d/graphic/56780.html" rel="external">algorithm 1</a>), clinical observation (<a class="graphic graphic_algorithm graphicRef131140" href="/z/d/graphic/131140.html" rel="external">algorithm 2</a>), and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fneonatalsepsiscalculator.kaiserpermanente.org%2F&amp;token=onMkmNxqZshoDc22JN8OR%2BQKCg7t0pcaNNq2h8esYG515dR4JaAxDq9tt4oaRDV5Qc%2FbUukpm4cZ872Q8bCopQ%3D%3D&amp;TOPIC_ID=5043" target="_blank">EOS calculator</a>. The EOS calculator is discussed above (see <a class="local">'Early-onset sepsis calculator'</a> above). The other two approaches are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5981.html" rel="external">"Management of neonates at risk for early-onset group B streptococcal infection", section on 'Approaches to risk assessment'</a>.)</p><p class="headingAnchor" id="H96559382"><span class="h2">Late-onset presentation</span><span class="headingEndMark"> — </span>Neonates presenting with signs of infection at ≥72 hours of age should undergo prompt evaluation and empiric antibiotic treatment. (See <a class="local">'Empiric antibiotic therapy'</a> below.)</p><p>At a minimum, the evaluation should include <strong>all</strong> of the following tests to evaluate for bacterial sepsis:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood culture (see <a class="local">'Blood culture'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>LP (if the neonate is clinically stable enough to tolerate the procedure and it will not delay initiation of antibiotic therapy) (see <a class="local">'Lumbar puncture'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Chest radiograph (if respiratory symptoms are present)</p><p class="bulletIndent1"><span class="glyph">●</span>Urine culture (see <a class="local">'Urine culture'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Cultures from any other potential foci of infection (eg, tracheal aspirates if intubated, purulent eye drainage, or pustules) (see <a class="local">'Other cultures'</a> below)</p><p></p><p>Neonates with LOS generally present to the outpatient or emergency department (ED) setting unless a comorbid condition prolongs the birth hospitalization. Neonates presenting to the outpatient or ED setting with fever or other concerning findings may require additional evaluation for nonbacterial causes. The approach is discussed in separate topics: </p><p class="bulletIndent1"><span class="glyph">●</span>Febrile well-appearing neonates – The approach to evaluating well-appearing febrile neonates presenting to the outpatient or ED setting is summarized in the figure (<a class="graphic graphic_algorithm graphicRef132304" href="/z/d/graphic/132304.html" rel="external">algorithm 3</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on '8 to 21 days old'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ill-appearing neonates – Although infection is one of the most common causes of ill appearance in young infants, many other clinical conditions have similar manifestations (<a class="graphic graphic_table graphicRef74535" href="/z/d/graphic/74535.html" rel="external">table 3</a>). The approach to evaluating an ill-appearing neonate is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6467.html" rel="external">"Approach to the ill-appearing infant (younger than 90 days of age)"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for viral etiology – In addition to tests to identify bacterial pathogens, diagnostic testing for viral etiologies may be warranted in selected patients:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Herpes simplex virus (HSV) – Infants with clinical suspicion for HSV infection warrant additional blood and cerebrospinal fluid (CSF) studies, surface viral cultures, and scraping from skin vesicles or mucous membranes for additional testing, as summarized in the table (<a class="graphic graphic_table graphicRef106132" href="/z/d/graphic/106132.html" rel="external">table 4</a>) and described separately. (See  <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">"Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Evaluation and diagnosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other viruses – Testing for common viral infections (eg, respiratory syncytial virus [RSV], influenza, severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), may be warranted depending on the season and constellation of findings. Neonates &lt;28 days of age who are diagnosed with viral infections still have a significant risk for bacterial sepsis and warrant a full sepsis evaluation and empiric treatment pending cultures. (See  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on 'Ancillary studies'</a> and  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on 'Diagnosed with viral infections'</a>.)</p><p></p><p class="headingAnchor" id="H99925411"><span class="h2">Empiric antibiotic therapy</span><span class="headingEndMark"> — </span>Indications for empiric antibiotic therapy (after obtaining cultures) include:</p><p class="bulletIndent1"><span class="glyph">●</span>Ill appearance (see  <a class="medical medical_review" href="/z/d/html/6467.html" rel="external">"Approach to the ill-appearing infant (younger than 90 days of age)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Concerning symptoms, including temperature instability or respiratory, cardiocirculatory, or neurologic symptoms (see <a class="local">'Clinical manifestations'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>High estimated risk of EOS based on a validated risk <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fneonatalsepsiscalculator.kaiserpermanente.org%2F&amp;token=onMkmNxqZshoDc22JN8OR%2BQKCg7t0pcaNNq2h8esYG515dR4JaAxDq9tt4oaRDV5Qc%2FbUukpm4cZ872Q8bCopQ%3D%3D&amp;TOPIC_ID=5043" target="_blank">calculator</a> (see <a class="local">'Early-onset sepsis calculator'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CSF pleocytosis (white blood cell [WBC] count of &gt;20 to 30 cells/microL) (<a class="graphic graphic_table graphicRef54464" href="/z/d/graphic/54464.html" rel="external">table 5</a>) (see  <a class="medical medical_review" href="/z/d/html/6005.html" rel="external">"Bacterial meningitis in the neonate: Clinical features and diagnosis", section on 'Interpretation of cerebrospinal fluid'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Positive blood, urine, or CSF culture</p><p></p><p>The empiric antibiotic regimen should include agents active against GBS and other organisms that most commonly cause neonatal sepsis (eg, <em>E</em>. <em>coli</em> and other gram-negative pathogens) (<a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">table 1</a>). Our suggested empiric regimens are summarized in the table (<a class="graphic graphic_table graphicRef102574" href="/z/d/graphic/102574.html" rel="external">table 6</a>) and discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates", section on 'Initial empiric therapy'</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">LABORATORY TESTS</span><span class="headingEndMark"> — </span>The goals of the diagnostic evaluation are to identify and treat all neonates with bacterial sepsis and minimize the treatment of patients who are not infected. Laboratory assessment includes cultures of body fluids that confirm the presence or absence of a bacterial pathogen and other studies that are used to evaluate the likelihood of infection.</p><p class="headingAnchor" id="H15"><span class="h2">Blood culture</span><span class="headingEndMark"> — </span>A definitive diagnosis of neonatal sepsis is established by a positive blood culture. The sensitivity of a single blood culture (with ≥1 mL of blood) to detect neonatal bacteremia approaches 90 percent [<a href="#rid39">39</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood sampling</strong> – The following considerations are important when obtaining a blood culture:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sampling site</strong> – Blood cultures can be obtained by venipuncture or arterial puncture or by sampling from a newly inserted umbilical artery or vascular access catheter. Positive culture results of blood drawn from indwelling umbilical or central venous catheters can be difficult to interpret since they can indicate contamination or catheter colonization rather than a true systemic infection. In such circumstances, obtaining a peripheral blood culture may help determine if there is a true bloodstream infection [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Number of cultures</strong> – We obtain at least one culture prior to initiating empiric antibiotic therapy in neonates with a high clinical suspicion for sepsis, although other institutions may routinely obtain two blood cultures.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Volume of blood</strong> – The optimal volume of blood is based on the weight of the neonate. A <strong>minimum</strong> blood volume of 1 mL is desirable for optimal detection of bacteremia when a single blood culture bottle is used [<a href="#rid3">3</a>]. At the author's institution, the suggested optimal volume is 2 mL for neonates weighing ≤3 kg and 3 mL for those who weigh &gt;3 to 5 kg. Dividing this volume into two aliquots to inoculate an anaerobic as well as the aerobic culture bottle may optimize recovery of rare strict anaerobic species, and most neonatal pathogens grow under anaerobic conditions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Time to positivity</strong> – Automated systems for continuous monitoring of blood cultures are routinely used in the United States and have shortened the time to identify positive blood cultures. In most cases of neonatal sepsis, blood cultures become positive within 24 to 36 hours [<a href="#rid40">40,41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Distinguishing infection from contamination</strong> – A positive blood culture is diagnostic of sepsis when a known bacterial pathogen is isolated (<a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">table 1</a>). Isolation of skin flora (eg, diphtheroids) suggests contamination rather than infection. Contamination is also suggested when multiple species grow in culture. Coagulase-negative staphylococci may be pathogenic in patients with indwelling vascular catheters or other invasive devices, whereas a single blood culture positive for coagulase-negative staphylococci is likely to represent a contaminant in full-term neonates without these risk factors [<a href="#rid7">7</a>].</p><p></p><p class="headingAnchor" id="H103633428"><span class="h2">Lumbar puncture</span><span class="headingEndMark"> — </span>Specific clinical signs of meningitis (eg, bulging fontanelle, nuchal rigidity) may be lacking in neonates. For this reason, we suggest performing LP in all neonates with suspected LOS, provided the neonate is stable enough to tolerate the procedure and it will not delay initiation of antibiotics. We also suggest performing LP in the evaluation of suspected EOS if the newborn is ill appearing or has other concerning findings (irritability, bulging fontanelle, seizures). Other experts advise performing LP in all neonates undergoing evaluation for clinically suspected EOS. LP is <strong>not</strong> necessary in well-appearing newborns undergoing evaluation for EOS based upon identified risk factors, as discussed above (see <a class="local">'Well-appearing neonates'</a> above). However, LP should be performed if the blood culture is positive [<a href="#rid3">3</a>]. </p><p>If LP is performed, cerebrospinal fluid should be sent for Gram stain, routine culture, cell count with differential, and protein and glucose concentrations. The interpretation of cerebrospinal fluid needs to account for variations due to gestational age, chronologic age, and birth weight (<a class="graphic graphic_table graphicRef54464" href="/z/d/graphic/54464.html" rel="external">table 5</a>).</p><p>The clinical features and diagnosis of neonatal bacterial meningitis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6005.html" rel="external">"Bacterial meningitis in the neonate: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H103633258"><span class="h2">Urine culture</span><span class="headingEndMark"> — </span>Urine culture obtained by catheter or bladder tap should be included in the evaluation for LOS (ie, onset at ≥72 hours after birth). A urine culture need not be routinely performed in the evaluation of suspected EOS (onset within the first 72 hours after birth), because a positive urine culture in this setting is a reflection of high-grade bacteremia rather than an isolated urinary tract infection [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/4959.html" rel="external">"Urinary tract infections in neonates"</a>.)</p><p class="headingAnchor" id="H103633302"><span class="h2">Other cultures</span><span class="headingEndMark"> — </span>In neonates with late-onset infection, cultures should be obtained from any other potential foci of infection (eg, purulent eye drainage or pustules).</p><p>Tracheal aspirates can be of value if obtained immediately after first intubation. However, the trachea and proximal bronchi are not sterile, so a positive tracheal culture may represent colonization rather than infection, particularly in a neonate who has been intubated for several days.</p><p>Gram stain or culture of other sites (eg, gastric aspirate, body surface sites [eg, axilla, groin, and external ear canal]) add little to the evaluation and should <strong>not</strong> be performed [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H686757573"><span class="h2">Complete blood count</span><span class="headingEndMark"> — </span>The CBC has poor sensitivity and specificity and cannot establish or exclude the diagnosis of neonatal sepsis. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early-onset sepsis </strong>–<strong> </strong>For most neonates with suspected EOS, we suggest <strong>not</strong> obtaining a CBC as part of the diagnostic evaluation. The CBC does not perform well in predicting risk of EOS in neonates, it adds little information, and does not impact clinical decisions. If a CBC is obtained, it should not be used as the sole determinant of whether to treat empirically with antibiotics [<a href="#rid42">42-46</a>]. The CBC can be used in combination with risk factors, clinical assessment, and/or other tests. However, it adds little to these other assessments. CBCs obtained 6 to 12 hours after delivery are more predictive of sepsis than those obtained immediately after birth because the white blood cell count (WBC) and absolute neutrophil count (ANC) normally increase during the first six hours after birth [<a href="#rid42">42,43,47,48</a>].</p><p></p><p class="bulletIndent1">Large multicenter studies have evaluated the diagnostic value of CBCs in neonatal EOS [<a href="#rid5">5,42,43,49-51</a>]. These studies demonstrated correlations between various WBC parameters (including WBC count, ANC, and ratio of immature to total neutrophils [I/T ratio]) and culture-proven sepsis; however, none were sufficiently sensitive or specific to reliably predict neonatal sepsis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-onset sepsis</strong> – CBCs are less variable at &gt;72 hours after birth than they are in the first few days of life. However, WBC indices still perform poorly in identifying neonates with LOS [<a href="#rid52">52</a>]. At the authors institution, we do not use CBCs in the evaluation of suspected LOS among infants who remain hospitalized since birth. The role of CBCs in the outpatient evaluation of well-appearing febrile neonates is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on '8 to 21 days old'</a>.) </p><p></p><p class="headingAnchor" id="H16"><span class="h2">Other inflammatory markers</span><span class="headingEndMark"> — </span>A number of acute phase reactants have been used to identify infected newborns. Many of these tests have acceptable sensitivity; however, they all lack specificity, resulting in poor positive predictive value [<a href="#rid53">53</a>]. No single biomarker or panel of screening tests is sufficiently sensitive to reliably detect neonatal sepsis [<a href="#rid54">54</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>C-reactive protein (CRP)</strong> – CRP is increased in inflammatory conditions, including sepsis. A variety of noninfectious inflammatory conditions can also cause elevated CRP, including maternal fever, fetal distress, stressful delivery, perinatal asphyxia, meconium aspiration, and intraventricular hemorrhage [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1">A single measurement of CRP is not a useful aid in the diagnosis of neonatal sepsis, because it lacks sufficient sensitivity and specificity [<a href="#rid56">56</a>]. However, sequential assessment of CRP values may help to exclude the diagnosis of sepsis since if the CRP level remains persistently normal (&lt;1 mg/dL [10 mg/L]), bacterial sepsis is unlikely [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1">However, we do not routinely use serial CRP measurements for this purpose since this practice appears to be associated with higher rates of initiating antibiotics and longer duration of hospitalization without any clear benefit [<a href="#rid57">57,58</a>].</p><p></p><p class="bulletIndent1">An elevated CRP level alone does not justify continuation of empiric antibiotics for more than 36 to 48 hours in well-appearing neonates with negative culture results [<a href="#rid59">59</a>]. Additional evaluation may be warranted to investigate alternative explanations for persistently elevated CRP values.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procalcitonin (PCT)</strong> – PCT is the peptide precursor of calcitonin. It is released by parenchymal cells in response to bacterial toxins, leading to elevated serum levels in patients with bacterial infections. Several observational studies have suggested that elevated PCT levels are associated with infection in neonates [<a href="#rid60">60-62</a>]. In a systematic review of 18 studies, the sensitivity of PCT for detecting neonatal sepsis ranged from 72 to 79 percent, and the specificity ranged from 72 to 90 percent [<a href="#rid62">62</a>]. Thus, although PCT is a promising marker, it does not appear to be reliable as the sole or main diagnostic indicator for neonatal sepsis.</p><p></p><p class="bulletIndent1">A randomized clinical trial suggested that adding serial PCT measurements to other standard assessments (ie, clinical examination and culture results) may shorten duration of antibiotic therapy [<a href="#rid63">63</a>]. However, in this trial, the treating clinicians overruled the study protocol's suggested duration of antibiotic therapy in &gt;40 percent of the enrolled neonates, which limits the certainty of the study's findings. Additional data are needed before monitoring PCT levels can be adopted into routine neonatal clinical practice. If PCT levels are obtained, they should be used in conjunction with other clinical indicators of sepsis and should not be the sole basis of decision-making.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cytokines, chemokines, and other biomarkers</strong> – Both proinflammatory cytokines, such as interleukin-6 and tumor necrosis factor-alpha, and anti-inflammatory cytokines (interleukin-4 and interleukin-10) are increased in infected neonates compared with those without infections [<a href="#rid64">64-67</a>]. Elevations of serum amyloid A and the cell surface antigen CD64 also have high sensitivity for identifying neonates with sepsis [<a href="#rid62">62,68</a>]. However, these biomarkers are generally not used in clinical practice.</p><p></p><p class="headingAnchor" id="H19"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of sepsis is based upon isolating a pathogenic organism in culture. Few neonates who undergo sepsis evaluation are ultimately diagnosed with sepsis.</p><p>This was demonstrated in a retrospective study of 2785 newborns who underwent evaluation for sepsis based on clinical symptoms (54 percent) or risk factors (46 percent) [<a href="#rid5">5</a>]. Culture-proven sepsis was identified in 22 neonates (0.8 percent) and culture-negative clinical sepsis ("probable sepsis") was diagnosed in 40 neonates (1.4 percent). </p><p class="headingAnchor" id="H366942293"><span class="h2">Culture-proven sepsis</span><span class="headingEndMark"> — </span>The isolation of pathogenic bacteria from a blood culture is the gold standard to confirm the diagnosis of neonatal sepsis. A positive blood culture is diagnostic of sepsis when a pathogenic organism is isolated (<a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">table 1</a>). Isolation of skin flora (eg, diphtheroids and coagulase-negative staphylococci) in culture suggests contamination rather than infection, although coagulase-negative staphylococci can be pathogenic in patients with indwelling vascular catheters or other devices [<a href="#rid7">7</a>]. (See <a class="local">'Blood culture'</a> above and  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates", section on 'Culture-proven sepsis'</a>.)</p><p class="headingAnchor" id="H366942300"><span class="h2">Probable sepsis</span><span class="headingEndMark"> — </span>In some cases, a pathogen may not be isolated in culture, yet the neonate has a clinical course that is concerning for sepsis (eg, ongoing temperature instability; ongoing respiratory, cardiocirculatory, or neurologic symptoms not explained by other conditions; or laboratory abnormalities suggestive of sepsis [cerebrospinal fluid pleocytosis, persistently elevated C-reactive protein]).</p><p>A composite of observational assessment and serial laboratory testing is typically used to make a diagnosis of probable sepsis [<a href="#rid69">69</a>]. The criteria used are usually broad in an attempt to ensure that all infected neonates are identified, but at the cost of testing and treating a number of uninfected neonates. There is no consensus definition for the clinical diagnosis of probable sepsis in neonates [<a href="#rid70">70</a>].</p><p>Alternative diagnoses (<a class="graphic graphic_table graphicRef100409" href="/z/d/graphic/100409.html" rel="external">table 7</a>) should also be entertained when a neonate with suspected sepsis has negative cultures. (See  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates", section on 'Probable but unproven sepsis'</a> and <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H366942319"><span class="h2">Infection unlikely</span><span class="headingEndMark"> — </span>Neonates with mild and/or transient symptoms (ie, fever alone or other symptoms that quickly resolve) who remain well-appearing with negative cultures at 36 to 48 hours are unlikely to have sepsis. Empiric antibiotic therapy should be discontinued after 36 to 48 hours in these neonates [<a href="#rid3">3,71</a>].</p><p class="headingAnchor" id="H22"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of neonatal sepsis includes systemic viral, fungal, and parasitic infections and noninfectious causes of temperature instability and respiratory, cardiocirculatory, and neurologic symptoms (<a class="graphic graphic_table graphicRef100409" href="/z/d/graphic/100409.html" rel="external">table 7</a>). The clinical history, disease course, and laboratory findings may help to distinguish neonatal sepsis from other infectious and noninfectious disorders. Ultimately, appropriate microbiologic testing is required to confirm the diagnosis.</p><p>It is often difficult to differentiate neonatal sepsis from other conditions. However, given the morbidity and mortality of neonatal sepsis, empiric antibiotic therapy should be provided (after obtaining cultures) to infants with suspected sepsis pending definitive culture-based diagnosis.</p><p class="headingAnchor" id="H2327855457"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110817.html" rel="external">"Society guideline links: Sepsis in neonates"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/112235.html" rel="external">"Society guideline links: Group B streptococcal infection in pregnant women and neonates"</a>.)</p><p class="headingAnchor" id="H164565741"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/17189.html" rel="external">"Patient education: Sepsis in newborn babies (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology and microbiology</strong> – Sepsis is an important cause of morbidity and mortality in newborn infants.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Incidence – The incidence of bacterial sepsis in term neonates is approximately one to two cases per 1000 live births; the rate is slightly higher in late preterm neonates (approximately four to five cases per 1000 births). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Common pathogens – Group B <em>Streptococcus</em> (GBS) and <em>Escherichia</em> <em>coli</em> are the most common bacteria causing neonatal sepsis in term infants. Other pathogens are summarized in the table (<a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">table 1</a>). (See <a class="local">'Etiologic agents'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maternal risk factors – Maternal risk factors for early-onset neonatal sepsis include intra-amniotic infection, intrapartum fever, preterm delivery, maternal GBS colonization, and prolonged rupture of membranes. (See  <a class="medical medical_review" href="/z/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Identification of pregnancies at increased risk for early-onset neonatal GBS'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Clinical manifestations are nonspecific and include (<a class="graphic graphic_table graphicRef72985" href="/z/d/graphic/72985.html" rel="external">table 2</a>) (see <a class="local">'Clinical manifestations'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal distress</p><p class="bulletIndent2"><span class="glyph">•</span>Temperature instability (fever or hypothermia)</p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory and cardiocirculatory symptoms (most commonly respiratory distress and tachycardia)</p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic symptoms (irritability, lethargy, poor tone, and seizures)</p><p class="bulletIndent2"><span class="glyph">•</span>Gastrointestinal abnormalities (poor feeding, vomiting, and abdominal distension) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation of suspected early-onset sepsis (EOS)</strong> – The evaluation of a neonate with suspected sepsis within first 72 hours after birth includes review of the pregnancy, labor, and delivery; physical examination; and laboratory evaluation directed by the neonate's signs and symptoms (if present) and maternal risk factors (see <a class="local">'Early-onset presentation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic newborns</strong> – Neonates with clinical signs of EOS (<a class="graphic graphic_table graphicRef72985" href="/z/d/graphic/72985.html" rel="external">table 2</a>) should undergo a full diagnostic evaluation and should receive empiric antibiotic treatment as summarized in the table (<a class="graphic graphic_table graphicRef102574" href="/z/d/graphic/102574.html" rel="external">table 6</a>) and discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates", section on 'Early-onset sepsis'</a>.)</p><p></p><p class="bulletIndent2">The evaluation includes:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Blood culture (see <a class="local">'Blood culture'</a> above)</p><p class="bulletIndent3"><span class="glyph">-</span>Lumbar puncture (LP) if the newborn is ill-appearing or if there are other concerning signs (irritability, bulging fontanelle, seizures) (see <a class="local">'Lumbar puncture'</a> above) </p><p class="bulletIndent3"><span class="glyph">-</span>Chest radiograph if there are respiratory findings</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Well-appearing newborns</strong> – The approach to evaluating well-appearing newborns who have risk factors for EOS is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5981.html" rel="external">"Management of neonates at risk for early-onset group B streptococcal infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation of suspected late-onset sepsis (LOS)</strong> – Neonates presenting with clinical signs of sepsis at ≥72 hours after birth should undergo a full diagnostic evaluation and should receive empiric antibiotic treatment as summarized in the table (<a class="graphic graphic_table graphicRef102574" href="/z/d/graphic/102574.html" rel="external">table 6</a>) and discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates", section on 'Early-onset sepsis'</a>.)</p><p></p><p class="bulletIndent1">At a minimum, the evaluation for LOS should include <strong>all</strong> of the following tests to evaluate for bacterial sepsis (see <a class="local">'Late-onset presentation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Blood culture (see <a class="local">'Blood culture'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>LP (provided the neonate is stable enough to tolerate the procedure and it will not delay antibiotic therapy) (see <a class="local">'Lumbar puncture'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Chest radiograph (if respiratory symptoms are present)</p><p class="bulletIndent2"><span class="glyph">•</span>Urine culture (see <a class="local">'Urine culture'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Cultures from any other potential foci of infection (eg, tracheal aspirates if intubated, purulent eye drainage, or pustules) (see <a class="local">'Other cultures'</a> above)</p><p></p><p class="bulletIndent1">Neonates &lt;28 days presenting to the outpatient or emergency department setting with fever or other concerning findings may require additional evaluation for nonbacterial causes. The approach is discussed in separate topics. (See  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/6467.html" rel="external">"Approach to the ill-appearing infant (younger than 90 days of age)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Isolation of a pathogen from a blood culture confirms the diagnosis of neonatal sepsis. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of neonatal sepsis includes other systemic infections and noninfectious conditions including respiratory diseases (eg, transient tachypnea of the newborn and respiratory distress syndrome), cardiac diseases (eg, congenital heart disease and supraventricular tachycardia), neurologic injury (eg, from anoxia or hemorrhage), inborn errors of metabolism, and neonatal abstinence syndrome (<a class="graphic graphic_table graphicRef100409" href="/z/d/graphic/100409.html" rel="external">table 7</a>). (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006; 118:1207.</a></li><li class="breakAll">American Academy of Pediatrics. Group B streptococcal infections. In: Red Book: 2021 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, 2021. p.707.</li><li><a class="nounderline abstract_t">Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2018; 142.</a></li><li><a class="nounderline abstract_t">Jefferies AL. Management of term infants at increased risk for early-onset bacterial sepsis. Paediatr Child Health 2017; 22:223.</a></li><li><a class="nounderline abstract_t">Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants &gt;/=2000 grams at birth: A population-based study. Pediatrics 2000; 106:256.</a></li><li><a class="nounderline abstract_t">Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999; 94:274.</a></li><li class="breakAll">Nizet V, Klein JO. Bacterial sepsis and meningitis. In: Infectious diseases of the Fetus and Newborn Infant, 8th ed, Remington JS, et al (Eds), Elsevier Saunders, Philadelphia 2016. p.217.</li><li><a class="nounderline abstract_t">Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 2018; 6:223.</a></li><li><a class="nounderline abstract_t">Oza S, Lawn JE, Hogan DR, et al. Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000-2013. Bull World Health Organ 2015; 93:19.</a></li><li><a class="nounderline abstract_t">Bailit JL, Gregory KD, Reddy UM, et al. Maternal and neonatal outcomes by labor onset type and gestational age. Am J Obstet Gynecol 2010; 202:245.e1.</a></li><li><a class="nounderline abstract_t">Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011; 30:937.</a></li><li><a class="nounderline abstract_t">Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127:817.</a></li><li><a class="nounderline abstract_t">Stoll BJ, Puopolo KM, Hansen NI, et al. Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. JAMA Pediatr 2020; 174:e200593.</a></li><li><a class="nounderline abstract_t">Giannoni E, Agyeman PKA, Stocker M, et al. Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study. J Pediatr 2018; 201:106.</a></li><li><a class="nounderline abstract_t">Cohen-Wolkowiez M, Moran C, Benjamin DK, et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J 2009; 28:1052.</a></li><li><a class="nounderline abstract_t">Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056.</a></li><li><a class="nounderline abstract_t">Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005; 116:595.</a></li><li><a class="nounderline abstract_t">van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, et al. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010; 97:22.</a></li><li><a class="nounderline abstract_t">Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010; 125:e1031.</a></li><li><a class="nounderline abstract_t">Bauserman MS, Laughon MM, Hornik CP, et al. Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis. Pediatr Infect Dis J 2013; 32:208.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus 2000. http://www.cdc.gov/abcs/reports-findings/survreports/gbs00.pdf (Accessed on March 29, 2013).</li><li class="breakAll">Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network, group B Streptococcus, 2021. Available at: https://www.cdc.gov/abcs/downloads/GBS_Surveillance_Report_2021.pdf (Accessed on October 16, 2023).</li><li><a class="nounderline abstract_t">Schrag SJ, Farley MM, Petit S, et al. Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Kuhn P, Dheu C, Bolender C, et al. Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics. Paediatr Perinat Epidemiol 2010; 24:479.</a></li><li><a class="nounderline abstract_t">Gottlieb SL, Newbern EC, Griffin PM, et al. Multistate outbreak of Listeriosis linked to turkey deli meat and subsequent changes in US regulatory policy. Clin Infect Dis 2006; 42:29.</a></li><li><a class="nounderline abstract_t">Okike I, Lamont R, Heath P. Do We Really Need to Worry About Listeria in Newborn Infants? Pediatr Infect Dis J 2013; 32:405.</a></li><li><a class="nounderline abstract_t">Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118:874.</a></li><li><a class="nounderline abstract_t">Gordon A, Isaacs D. Late onset neonatal Gram-negative bacillary infection in Australia and New Zealand: 1992-2002. Pediatr Infect Dis J 2006; 25:25.</a></li><li><a class="nounderline abstract_t">Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011; 128:e1155.</a></li><li><a class="nounderline abstract_t">Nanduri SA, Petit S, Smelser C, et al. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance. JAMA Pediatr 2019; 173:224.</a></li><li><a class="nounderline abstract_t">Osborn LM, Bolus R. Temperature and fever in the full-term newborn. J Fam Pract 1985; 20:261.</a></li><li><a class="nounderline abstract_t">Voora S, Srinivasan G, Lilien LD, et al. Fever in full-term newborns in the first four days of life. Pediatrics 1982; 69:40.</a></li><li><a class="nounderline abstract_t">Anand V, Nair PM. Neonatal seizures: Predictors of adverse outcome. J Pediatr Neurosci 2014; 9:97.</a></li><li><a class="nounderline abstract_t">Pong A, Bradley JS. Bacterial meningitis and the newborn infant. Infect Dis Clin North Am 1999; 13:711.</a></li><li><a class="nounderline abstract_t">Puopolo KM, Lynfield R, Cummings JJ, et al. Management of Infants at Risk for Group B Streptococcal Disease. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestation. Pediatrics 2014; 133:30.</a></li><li><a class="nounderline abstract_t">Kuzniewicz MW, Puopolo KM, Fischer A, et al. A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis. JAMA Pediatr 2017; 171:365.</a></li><li class="breakAll">Kaiser Permanente neonatal early-onset sepsis calculator. Available at: https://neonatalsepsiscalculator.kaiserpermanente.org.</li><li><a class="nounderline abstract_t">Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996; 129:275.</a></li><li><a class="nounderline abstract_t">Kuzniewicz MW, Mukhopadhyay S, Li S, et al. Time to Positivity of Neonatal Blood Cultures for Early-onset Sepsis. Pediatr Infect Dis J 2020; 39:634.</a></li><li><a class="nounderline abstract_t">Mukhopadhyay S, Briker SM, Flannery DD, et al. Time to positivity of blood cultures in neonatal late-onset bacteraemia. Arch Dis Child Fetal Neonatal Ed 2022; 107:583.</a></li><li><a class="nounderline abstract_t">Newman TB, Puopolo KM, Wi S, et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126:903.</a></li><li><a class="nounderline abstract_t">Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:799.</a></li><li><a class="nounderline abstract_t">Hashavya S, Benenson S, Ergaz-Shaltiel Z, et al. The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: is it justified? Pediatr Infect Dis J 2011; 30:840.</a></li><li><a class="nounderline abstract_t">Greenberg DN, Yoder BA. Changes in the differential white blood cell count in screening for group B streptococcal sepsis. Pediatr Infect Dis J 1990; 9:886.</a></li><li><a class="nounderline abstract_t">Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003; 22:430.</a></li><li><a class="nounderline abstract_t">Newman TB, Puopolo KM, Wi S, et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126:903.</a></li><li><a class="nounderline abstract_t">Rozycki HJ, Stahl GE, Baumgart S. Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis. Pediatr Infect Dis J 1987; 6:440.</a></li><li><a class="nounderline abstract_t">Russell GA, Smyth A, Cooke RW. Receiver operating characteristic curves for comparison of serial neutrophil band forms and C reactive protein in neonates at risk of infection. Arch Dis Child 1992; 67:808.</a></li><li><a class="nounderline abstract_t">Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:16.</a></li><li><a class="nounderline abstract_t">Jackson GL, Engle WD, Sendelbach DM, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics 2004; 113:1173.</a></li><li><a class="nounderline abstract_t">Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:803.</a></li><li><a class="nounderline abstract_t">Malik A, Hui CP, Pennie RA, Kirpalani H. Beyond the complete blood cell count and C-reactive protein: a systematic review of modern diagnostic tests for neonatal sepsis. Arch Pediatr Adolesc Med 2003; 157:511.</a></li><li><a class="nounderline abstract_t">Iroh Tam PY, Bendel CM. Diagnostics for neonatal sepsis: current approaches and future directions. Pediatr Res 2017; 82:574.</a></li><li><a class="nounderline abstract_t">Pourcyrous M, Bada HS, Korones SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92:431.</a></li><li><a class="nounderline abstract_t">Brown JVE, Meader N, Cleminson J, McGuire W. C-reactive protein for diagnosing late-onset infection in newborn infants. Cochrane Database Syst Rev 2019; 1:CD012126.</a></li><li><a class="nounderline abstract_t">Dhudasia MB, Benitz WE, Flannery DD, et al. Diagnostic Performance and Patient Outcomes With C-Reactive Protein Use in Early-Onset Sepsis Evaluations. J Pediatr 2023; 256:98.</a></li><li><a class="nounderline abstract_t">Mukherjee A, Davidson L, Anguvaa L, et al. NICE neonatal early onset sepsis guidance: greater consistency, but more investigations, and greater length of stay. Arch Dis Child Fetal Neonatal Ed 2015; 100:F248.</a></li><li><a class="nounderline abstract_t">Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr 2015; 166:1070.</a></li><li><a class="nounderline abstract_t">Maniaci V, Dauber A, Weiss S, et al. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 2008; 122:701.</a></li><li><a class="nounderline abstract_t">Vouloumanou EK, Plessa E, Karageorgopoulos DE, et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 2011; 37:747.</a></li><li><a class="nounderline abstract_t">Hedegaard SS, Wisborg K, Hvas AM. Diagnostic utility of biomarkers for neonatal sepsis--a systematic review. Infect Dis (Lond) 2015; 47:117.</a></li><li><a class="nounderline abstract_t">Stocker M, van Herk W, El Helou S, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet 2017; 390:871.</a></li><li><a class="nounderline abstract_t">Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis 2008; 21:223.</a></li><li><a class="nounderline abstract_t">Panero A, Pacifico L, Rossi N, et al. Interleukin 6 in neonates with early and late onset infection. Pediatr Infect Dis J 1997; 16:370.</a></li><li><a class="nounderline abstract_t">Sherwin C, Broadbent R, Young S, et al. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am J Perinatol 2008; 25:629.</a></li><li><a class="nounderline abstract_t">Zhou M, Cheng S, Yu J, Lu Q. Interleukin-8 for diagnosis of neonatal sepsis: a meta-analysis. PLoS One 2015; 10:e0127170.</a></li><li><a class="nounderline abstract_t">Lynema S, Marmer D, Hall ES, et al. Neutrophil CD64 as a diagnostic marker of sepsis: impact on neonatal care. Am J Perinatol 2015; 32:331.</a></li><li><a class="nounderline abstract_t">Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004; 51:939.</a></li><li><a class="nounderline abstract_t">Wynn JL, Wong HR, Shanley TP, et al. Time for a neonatal-specific consensus definition for sepsis. Pediatr Crit Care Med 2014; 15:523.</a></li><li><a class="nounderline abstract_t">Polin RA, Watterberg K, Benitz W, Eichenwald E. The conundrum of early-onset sepsis. Pediatrics 2014; 133:1122.</a></li></ol></div><div id="topicVersionRevision">Topic 5043 Version 63.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16951017" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16951017" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30455342" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Management of Neonates Born at≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29480905" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Management of term infants at increased risk for early-onset bacterial sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10920148" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Neonatal sepsis workups in infants&gt;/=2000 grams at birth: A population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10432142" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Chorioamnionitis and the prognosis for term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10432142" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Chorioamnionitis and the prognosis for term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29508706" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The global burden of paediatric and neonatal sepsis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25558104" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20207242" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Maternal and neonatal outcomes by labor onset type and gestational age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21654548" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21518717" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32364598" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30054165" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19953725" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Early and late onset sepsis in late preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18460666" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16140698" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Seventy-five years of neonatal sepsis at Yale: 1928-2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19571584" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20385650" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23011013" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23011013" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23011013" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940705" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20670228" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16323088" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Multistate outbreak of Listeriosis linked to turkey deli meat and subsequent changes in US regulatory policy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Do We Really Need to Worry About Listeria in Newborn Infants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16950976" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16395098" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Late onset neonatal Gram-negative bacillary infection in Australia and New Zealand: 1992-2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22025590" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30640366" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3973542" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Temperature and fever in the full-term newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7033912" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Fever in full-term newborns in the first four days of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25250059" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Neonatal seizures: Predictors of adverse outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10470563" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Bacterial meningitis and the newborn infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31285392" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Management of Infants at Risk for Group B Streptococcal Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24366992" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Stratification of risk of early-onset sepsis in newborns≥34 weeks' gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28241253" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28241253" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8765627" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Volume of blood required to detect common neonatal pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32379197" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Time to Positivity of Neonatal Blood Cultures for Early-onset Sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35273079" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Time to positivity of blood cultures in neonatal late-onset bacteraemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20974782" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Interpreting complete blood counts soon after birth in newborns at risk for sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22531231" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Use of the complete blood cell count in early-onset neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21617574" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: is it justified?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2277744" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Changes in the differential white blood cell count in screening for group B streptococcal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12792384" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20974782" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Interpreting complete blood counts soon after birth in newborns at risk for sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3601489" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1519980" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Receiver operating characteristic curves for comparison of serial neutrophil band forms and C reactive protein in neonates at risk of infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21860335" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Use of leukocyte counts in evaluation of early-onset neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15121926" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22531232" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Use of the complete blood cell count in late-onset neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12796229" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Beyond the complete blood cell count and C-reactive protein: a systematic review of modern diagnostic tests for neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28574980" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Diagnostics for neonatal sepsis: current approaches and future directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8361798" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Significance of serial C-reactive protein responses in neonatal infection and other disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30640979" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : C-reactive protein for diagnosing late-onset infection in newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36529283" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Diagnostic Performance and Patient Outcomes With C-Reactive Protein Use in Early-Onset Sepsis Evaluations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25079114" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : NICE neonatal early onset sepsis guidance: greater consistency, but more investigations, and greater length of stay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25641240" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Reappraisal of guidelines for management of neonates with suspected early-onset sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18829791" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Procalcitonin in young febrile infants for the detection of serious bacterial infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21380522" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25522182" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Diagnostic utility of biomarkers for neonatal sepsis--a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28711318" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18448965" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Diagnostic tests in neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9109138" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Interleukin 6 in neonates with early and late onset infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18850512" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25996378" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Interleukin-8 for diagnosis of neonatal sepsis: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25077472" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Neutrophil CD64 as a diagnostic marker of sepsis: impact on neonatal care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15275982" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Diagnosis and management of bacterial infections in the neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24751791" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Time for a neonatal-specific consensus definition for sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24799547" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The conundrum of early-onset sepsis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
